Fidelity Investments’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Fidelity Investments’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-58,000	Closed	-$273K	–	2856
2015 Q1	$273K	Hold	58,000	–	–	﹤0.01%	2693
2014 Q4	$369K	Hold	58,000	–	–	﹤0.01%	2682
2014 Q3	$284K	Hold	58,000	–	–	﹤0.01%	2707
2014 Q2	$443K	Hold	58,000	–	–	﹤0.01%	2612
2014 Q1	$612K	Buy	+58,000	New	+$829K	﹤0.01%	2531

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Fidelity Investments's OCRX Position: Q2 2015 in Review

Fidelity Investments sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2015, closing a stake of 58,000 shares — an estimated $273K sold.

Fidelity Investments first reported a position in OCRX in Q1 2014 and held it in 5 quarters. The position peaked at $612K in Q1 2014. 32 funds tracked by Wall St. Rank hold OCRX as of Q2 2015.

Fidelity Investments reported no remaining Ocera Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
Fidelity Investments sold 58,000 Ocera Therapeutics, Inc. shares in Q2 2015, an estimated $273K.
Fidelity Investments first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 5 quarters.
Fidelity Investments's Ocera Therapeutics, Inc. position peaked at $612K in Q1 2014.
32 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2015.

Based on Fidelity Investments's 13F filing for Q2 2015, filed 13 Aug 2015.